News about Industrial talks

Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal

Valneva SE and the Serum Institute of India have mutually agreed to discontinue their licensing agreement for Valneva’s single-shot chikungunya vaccine, bringing the collaboration to a close by mutual consent.

Industrial talks | 01/01/2026 | By News Bureau

Cogent Biosciences Submits NDA for Bezuclastinib in Non Advanced Systemic Mastocytosis

Cogent Biosciences has submitted a New Drug Application to the US FDA for bezuclastinib in non-advanced systemic mastocytosis, supported by positive results from the SUMMIT pivotal trial and following its Breakthrough Therapy Designation for patients with smouldering systemic mastocytosis and previously treated NonAdvSM.

Industrial talks | 31/12/2025 | By News Bureau

Evogene Appoints Dr Olga Nissan as VP for Business Development

Evogene has appointed Dr Olga Nissan as Vice President of Business Development, effective 1 January, 2026, bringing to the role a seasoned biotechnology and pharmaceutical leader with extensive experience spanning R&D, clinical development and business operations across pharma, diagnostics and agri-biotechnology sectors.

Industrial talks | 31/12/2025 | By News Bureau

Akums Signs MoU with Sharda University Agra to Advance Pharma Research

Akums Drugs & Pharmaceuticals has entered into a Memorandum of Understanding (MoU) with Sharda University, Agra, to collaborate on pharmaceutical research, technology transfer, and skill development, with an emphasis on strengthening the linkage between academic research and industrial application.

Industrial talks | 29/12/2025 | By Darshana

WHO and AYUSH Ministry Hold Technical Meet on Integrating AYUSH into Global Health Standards

WHO and Ministry of AYUSH held a technical meeting to advance the integration of Ayurveda, Siddha and Unani (ASU) systems into global health standards, laying the groundwork for a Traditional Medicine (TM) module within the International Classification of Health Interventions (ICHI), with India supporting the required financial and technical frameworks.

Industrial talks | 22/12/2025 | By News Bureau

WHO Hosts 2nd Global Summit to Promote Innovation and Integration in Traditional Medicine

The World Health Organization’s second Global Summit on Traditional Medicine has convened global leaders, scientists and indigenous practitioners from over 100 countries, with key scientific initiatives and new commitments expected to advance the WHO Global Traditional Medicine Strategy 2025–2034.

Industrial talks | 19/12/2025 | By News Bureau

Lupin's Climate Targets Across All Emission Scopes Validated by SBTi

Global pharmaceutical major Lupin Limited has announced that its greenhouse gas emissions reduction targets have been officially validated by the Science Based Targets initiative. The validation covers Scope 1, Scope 2 and Scope 3 emissions, aligning Lupin’s climate strategy with the Paris Agreement goal of limiting global temperature rise to 1.5°C.

Industrial talks | 16/12/2025 | By Darshana

Indoco Receives USFDA EIR for Patalganga API Manufacturing Facility

Indoco has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its API manufacturing facility at Patalganga following an inspection conducted in the month of September.

Industrial talks | 15/12/2025 | By News Bureau

Jubilant Pharmova Appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics

Jubilant Pharmova has announced the appointment of Daniel J. O’Connor as CEO of its proprietary novel drugs business, Jubilant Therapeutics Inc.

Industrial talks | 02/12/2025 | By Dineshwori

Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions

Tsingke Biotech showcased its accelerated protein and antibody production platform at PEGS Europe 2025, announcing capabilities to generate proteins in as little as three days and antibodies within seven—offering a boost to biopharma developers seeking faster drug discovery timelines.

Industrial talks | 20/11/2025 | By Dineshwori